Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Research Tools and Instruments - Category 1 (<$150,000)

Université du Québec à Montréal

$21,061.00

Microporation as a new efficient approach for transfection

FY 2007-08

Summary
In this proposal, we are requesting the purchase of the Microporator MP-100 transfection system.  Based on preliminary data from both of our research group, this device should permit to introduce DNA or RNA molecules in an efficient manner in cells, which are refractory to such a procedure.  Numerous advantages can be cited to describe this apparatus such as its easy-to-use characteristic, its small size, its flexibility to different cells, etc.  This apparatus will be very beneficial to both B. Barbeau and C. Mounier's laboratories and will be used for projects related to the study of placenta development and hormone- and nutrient-based regulation of FAS and SCD1 enzymes.  These studies indeed involve human primary cells known as cytotrophoblast cells (placenta) and chicken embryo hepatocytes.  These cells are thereby difficult to easily transfer nucleic acids internally and early results from our laboratory suggest that the Microporator indeed provides the needed technology to achieve this goal in both cell context.  We believe that the success of these projects will therefore be assured by the acquisition of the Microporator allowing us to test our hypotheses in more physiologically relevant cell systems.  The data that will emanate from these experiments will greatly contribute in the understanding of the process of placenta development and gene regulation of liver enzymes.  However, these results also has a strong potential to benefit Canadians as the pathologies/disorders which are related to our research themes are important health issues in Canada, such as preeclampsia and other pregnancy-related disorders for the cytotrophoblast project and cancer and obesity for the studied FAS/SCD1 genes.
Program
Research Tools and Instruments - Category 1 (<$150,000)
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
360398-2008
Name nom
Barbeau, Benoit
Department département
Sciences biologiques
Organization id
57
Institution établissement
Université du Québec à Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2007
Competition year année de concours
2008
Award amount
21061
Program id
EQPEQ
Program name en
Research Tools and Instruments - Category 1 (<$150,000)
Program name fr
Outils et instruments de recherche - catégorie 1 (<150 000$)
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
32
Committee name en
Cell Biology
Committee name fr
Biologie cellulaire
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5202
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Virology
Research subject fr
Virologie
Partie
1
Nb partie
1
Application title
Microporation as a new efficient approach for transfection
Keyword
NA
Application summary
In this proposal, we are requesting the purchase of the Microporator MP-100 transfection system.  Based on preliminary data from both of our research group, this device should permit to introduce DNA or RNA molecules in an efficient manner in cells, which are refractory to such a procedure.  Numerous advantages can be cited to describe this apparatus such as its easy-to-use characteristic, its small size, its flexibility to different cells, etc.  This apparatus will be very beneficial to both B. Barbeau and C. Mounier's laboratories and will be used for projects related to the study of placenta development and hormone- and nutrient-based regulation of FAS and SCD1 enzymes.  These studies indeed involve human primary cells known as cytotrophoblast cells (placenta) and chicken embryo hepatocytes.  These cells are thereby difficult to easily transfer nucleic acids internally and early results from our laboratory suggest that the Microporator indeed provides the needed technology to achieve this goal in both cell context.  We believe that the success of these projects will therefore be assured by the acquisition of the Microporator allowing us to test our hypotheses in more physiologically relevant cell systems.  The data that will emanate from these experiments will greatly contribute in the understanding of the process of placenta development and gene regulation of liver enzymes.  However, these results also has a strong potential to benefit Canadians as the pathologies/disorders which are related to our research themes are important health issues in Canada, such as preeclampsia and other pregnancy-related disorders for the cytotrophoblast project and cancer and obesity for the studied FAS/SCD1 genes.
Université du Québec à Montréal - $21,061 Grant (2007… | Canada Spends